Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kyowa Kirin China Pharmaceutical Co., Ltd.

Clinical trials sponsored by Kyowa Kirin China Pharmaceutical Co., Ltd., explained in plain language.

Now part of Kyowa Kirin Co., Ltd. 4151 TOKYO

Chinese subsidiary of Kyowa Kirin, focused on developing and commercializing pharmaceutical products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New hope for rare skin cancer: targeted antibody tested in china

Disease control Ongoing

This study tests a drug called mogamulizumab in 23 Chinese adults with mycosis fungoides or Sézary syndrome, two types of skin lymphoma that have not responded to previous treatments. The drug is given as an IV infusion and aims to shrink or eliminate cancer in the skin, lymph no…

Phase: PHASE4 • Sponsor: Kyowa Kirin China Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 26, 2026 18:41 UTC